This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Impax Laboratories Announces The Alignment Of Quality And Manufacturing Operations Under The Leadership Of Jeffrey D. Nornhold

Stocks in this article: IPXL

HAYWARD, Calif., April 2, 2014 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that Jeffrey D. Nornhold has been appointed Senior Vice President, Technical Operations and will oversee the Company's manufacturing, supply chain, quality and technical operations. Mr. Nornhold previously served as the Company's Senior Vice President, Global Quality Affairs since March 2011.

Impax Laboratories, Inc.

Mark Fitch, Senior Vice President, Global Operations announced his plans to retire, but will continue to work with Nornhold to ensure a smooth transition. Since joining Impax in June of 2011, Fitch has partnered with Nornhold to enhance the Company's manufacturing and quality areas, and improve operating efficiencies. This includes improvements to the Company's Hayward facility, expansion of the Taiwan facility, the transfer of numerous currently approved and manufactured products from Hayward to Taiwan and building a highly qualified leadership team. 

"Working alongside Mark the past three years has been a great experience," said Nornhold. "We have collaborated on enhancing and improving the critical areas of quality, manufacturing and compliance."

"Jeff has done an outstanding job of building a highly skilled internal quality organization and establishing the foundation for sustainable quality and compliance", said Larry Hsu, Ph.D., President and CEO of Impax Laboratories. "We believe Jeff is the ideal person to manage this new structure, and effectively drive compliance, efficiencies and collaboration across these key business functions."

Mr. Nornhold has over 24 years of experience in pharmaceutical manufacturing and related technical operations. Prior to joining Impax in 2011, he gained a significant amount of Technical Operations experience at Watson Pharmaceuticals (now Actavis plc), serving as Vice President, Quality Operations - International, and was responsible for manufacturing sites for both dosage and active pharmaceutical ingredients outside of the U.S. He also served as Vice President, U.S. Quality Operations at Watson, leading the development and execution of quality initiatives for all U.S. sites. Prior to joining Watson in 2000, he held numerous leadership positions within the pharmaceuticals industry.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs